"Designing Growth Strategies is in our DNA"

U.S. Dialysis Services Market Size, Share & COVID-19 Impact Analysis, By Type (Hemodialy-sis, Peritoneal Dialysis), By End-user (Dialysis Center, Home Healthcare, Hospital) and Fore-cast, 2021-2028

Region : USA | Format: PDF | Report ID: FBI105704



Play Audio Listen to Audio Version

The U.S. dialysis services market size was valued USD 25.87 billion in 2020 and is anticipated to grow from USD 26.20 billion in 2021 to USD 32.46 billion in 2028, exhibiting a CAGR of 3.11% in the 2021-2028 period. Based on our analysis, the market displayed a lower growth of 1.19% in 2020 as compared to the average year-on-year growth during 2017-2028. The impact of pandemic has been unprecedented and staggering, with the industry witnessing a negative impact on demand amidst the pandemic. The growth in CAGR is attributable to this market's demand and growth, returning to pre-pandemic  levels once the pandemic is over.

The population of patients receiving dialysis persists to grow speedily in the U.S. every year. As per the national kidney foundation, in 2018, 785,883 Americans had kidney failure, and 554,038 of these patients received dialysis. However, a significant number of people lack access to kidney replacement therapy, and millions of people die of kidney failure every year, often without supportive care. Furthermore, a shift in the trend of the adoption of telehealth-based treatments is projected to boost the market growth during the forecast period.

For example, in the U.S., the Bipartisan Budget Act (federal statute formed with regards to spending and budget in the U.S.) was signed into law and came into effect on 1 January 2019. Furthermore, this law extended telehealth access to home patients. Therefore, is likely to propel the demand during the projected timeframe.

COVID-19 Pandemic Enhanced Growth Backed by Availability of Virtual Platform in the U.S. Dialysis Service Market

Dialysis centers are closed or converted into COVID-19 facilities to cope with the increasing patient load. In the present scenario, numerous facilities providing care to patients with End-Stage Renal Disease (ESRD) faced challenges in safeguarding patients and staff while providing clinical care. However, many companies offering virtual healthcare services witnessed strong growth in their sales.

For instance, in 2020, Baxter International, a global innovator in renal care, had launched Peritoneal Dialysis Excellence Academy, a new virtual training platform and educational resource center to help nurses advance their skills to deliver optimal patient care in the U.S. With an increasing need and desire for virtual education because of the pandemic, the resources were designed to offer a standardized and actionable curriculum.


Request a Free sample to learn more about this report.

Technological Advancement in Telehealth to Increase Market Potentiality

Advancements in any market are optimistic in influencing the U.S. dialysis services industry's potentiality and market price. Telehealth and dialysis both foster greater home-based care, less time period, and fewer trips to the clinic. It also helps to facilitate patient education about home modalities and self-care. Nephrologists and dialysis providers have implemented telehealth platforms to deliver care for patients receiving treatment. Telehealth platforms varied from video conferencing alone to platforms that also grant for self-scheduling, payment collection, and physician notifications. For example, in 2020, Fresenius Medical Care North America rolled out the plan of a new telehealth solution mainly for home patients. The company has more than 2700 in-center and home facilities. Telehealth aims to continue the rapid climb of home therapies by improving collaboration among patients, the clinical care team, and physicians.


Shift from Clinics to Home Healthcare Services to Propel Market Growth

Many patients with End-Stage Renal Disease (ESRD) shift from one kind of dialysis to another as per their routine. Some patients prefer to treat themselves at home, while others would rather have professionals treating them at clinics. It can be done at a speciality center or at home. However, there is a significant shift of patients from clinics to home healthcare as patients can dialyze from the ease of home.

Home hemodialysis has potential advantages over clinics or hospitals. Patients get the opportunity for more frequent and longer sessions. The adoption of home healthcare services helps to cope with the increasing numbers of people requiring treatment. For example, DaVita and Fresenius Medical Care offer two classes, one is hemodialysis that requires a machine and special filter, very similar to in clinics, and the other one is peritoneal.

Furthermore, Fresenius Medical Care is projecting to change some of the speciality clinics into 'transitional care units' to train people at home to boost the percentage of its U.S. customers using home care services by more than 15 percent in 2022. The company is also expanding in-home care with its acquisition of NxStage, a U.S. maker of home-use dialysis machines.

Rising Prevalence of Kidney Diseases in the United States to Boost Market Growth

The rise in the prevalence of end-stage renal diseases (ESRD) is increasing the demand for dialysis services in the U.S. as well as globally. With the current situation of the pandemic, the market is further estimated to grow due to the increased patient pool. For instance, according to National Health and Nutrition Examination Survey (NHANES), the prevalence of chronic kidney diseases (CKD) amongst U.S. adults is increasing. Nearly 15% of the adult population in the United States have chronic kidney diseases.

The factors responsible for the high prevalence of the disease in the include the aging population, diabetic people, hypertension, cardiovascular disease, and other conditions. Furthermore, according to reports published by The National Kidney Foundation (NKF) estimated that one in every three adults is at risk of kidney disease, and it is the leading cause of death in the United States.


Surging Patient Pool Opting for Kidney Transplantation Procedure to Hamper Growth

Kidney transplantation is an alternative for patients suffering from End-Stage Renal Diseases (ESRD) and chronic kidney diseases. Advancement in surgical tools has made kidney transplantation easier. As per U.S. government information on Organ donation and transplantation, there were 39,000 transplants performed in 2020, of which 22,010 were kidney transplants. In 2020, a partnership between the U.S. department of health and human services (HHS) and the American Society of Nephrologist (ASN) had launched KidneyX – a Kidney accelerator innovation for the prevention, diagnosis, and treatment of kidney diseases. The better results associated with kidney transplant and affordability of procedures is projected to affect the growth in the U.S. dialysis services industry during the forecast period.


By Dialysis Type Analysis

To know how our report can help streamline your business, Speak to Analyst

Increasing Prevalence of Hypertension and Diabetes to Drive This Segment

Based on dialysis type, the market is segmented into hemodialysis and peritoneal. The hemodialysis segment dominated the market and held the highest market revenue share in 2020. This segment is further divided into acute and chronic. The segmental dominance is attributable to the increase in the incidence of hypertension and diabetes. With reference to the Center for Disease Control and Prevention (CDC) report states that the prevalence of diabetes in 2020 is approximately 34 million in the United States. Furthermore, factor such as shortage in availability of kidneys for transplants is also likely to augment the growth of the market.

Furthermore, the increasing burden of acute and chronic renal disease, along with favorable reimbursement scenarios, chronic kidney diseases, and the growing number of end-stage renal disease (ESRD) patients, are anticipated to propel the expansion of the hemodialysis segment during the forecast period.

By End-user Analysis

Merger and Acquisition Activities by Foremost Players to Augment the Dialysis Center Segment

Based on the end-users, the market is segmented into dialysis centers, home healthcare, and hospitals. The dialysis center segment dominated the market in terms of share in 2020 and is expected to retain its position by the end of 2028. For example, DaVita and Fresenius medical care are experiencing M&A activities from private equity investors. In accordance with the report of the United States Renal Data system (USRDS), there are more than 7,500 centers in the U.S., of which DaVita has 2821 centers, and Fresenius has 2634 centers.

According to American renal Associates (ARA), a large-scale dialysis provider in the United States is focusing on joint ventures with nephrology physicians. ARA functions more than 240 dialysis clinics in partnership with around 400 nephrologist partners treating approximately 16,500 patients. Additionally, a rise in the facility visit is leading to the expansion of the segment.


Expansion of Dialysis Services across the U.S. to Lead to Intense Competition among Industry Players

The market is consolidated with key major players providing services in the country. Among all the key players, DaVita Inc. represents a significant U.S. dialysis services market share owing to its widespread facilities across states. This company is one of the leading providers of kidney dialysis services and related lab services. It owns approximately 2,800 outpatient facilities in the United States and provides acute inpatient services at approximately 900 hospitals. Most of the company's dialysis services are provided at its outpatient hemodialysis centers. Additionally, the incorporation of telehealth technology by companies like DaVita and Baxter, with their focus on acquisitions & partnerships to provide services to a large population, is anticipated to increase the potential of the industry during the forecast period.


  • Fresenius Medical Care AG & Co. (Bad Homburg, Germany)

  • DaVita Inc. (Denver, Colorado, United States)

  • American Renal® Associates (Beverly, Massachusetts, United States)

  • U.S. Renal Care, Inc.(  Plano, Texas, United States)

  • Satellite Healthcare (San Jose, United States)

  • Baxter (Illinois, United States)

  • B. Braun Melsungen AG, (Melsungen, Germany)

  • Becton, Dickinson, and Company (New Jersey, United States)

  • DCI Inc. (Tennessee, United States)

  • NxStage Medical, Inc. (Massachusetts, United States)

  • Other Prominent Players


  • June 2019 - Baxter International Inc. had commenced share source 2.0 clinical portal (a telehealth platform), which brings insights to patients for home peritoneal dialysis treatments. The methodology of remote patient management technology assisted the company in strengthening its customer base.

  • October 2019 - Fresenius Medical Care ag co kgaa announced the acquisition NxStage Medical, Inc. (a U.S.-based home dialysis leader). This acquisition will help the company expand the manufacturing marketing and supply chain competencies across the market.


An Infographic Representation of U.S. Dialysis Services Market

To get information on various segments, share your queries with us

The report offers an elaborative and competitive landscape analysis of numerous factors affecting the market. It focuses on crucial aspects such as leading companies, types, and end-users. Additionally, it offers insights into the U.S. dialysis services market trends and highlights dynamic industry developments. In addition to the factors mentioned above, the report comprehends various factors that have contributed to the market's growth over recent years. It analyzes many strategies such as product innovations, mergers, alliances, joint ventures, and acquisitions adopted by the industry players.




Study Period


Base Year


Estimated Year


Forecast Period


Historical Period



  Value (USD Billion)


  By Type; By End User

By Type

  • Hemodialysis

    • Acute

    • Chronic

  • Peritoneal Dialysis

By End-User

  • Dialysis center

  • Home Healthcare

  • Hospital

Frequently Asked Questions

Fortune Business Insights says that the U.S dialysis services market size was USD 25.87 billion in 2020 and is projected to reach USD 32.46 billion by 2028.

Registering a CAGR of 3.11%, the market will exhibit steady growth in the forecasted timeframe.

Hemodialysis segment is estimated to lead this market during the projected timeframe.

The increasing prevalence of End-Stage Renal Diseases and the rising rate of diabetes and hy-pertension are the key factors driving the market.

Fresenius Medical Care AG & Co, DaVita Inc., and American Renal Associates are some of the leading companies in the market.

Acquisitions, partnerships, the advent of telehealth services, and the establishment of ad-vanced facilities are expected to drive the adoption of dialysis services in the U.S.

Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts

Speak to an Expert
  • Aug, 2021
  • 2020
  • 2017-2019
  • 90


  • $2850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients


Client Testimonials

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- UGlobal hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.